Heart Disease News and Research

Latest Heart Disease News and Research

Experts: Tobacco-style health warning labels are mandatory on salt shakers

Salt sold in supermarkets and salt shakers in restaurants should be required to carry a front-of-pack, tobacco-style health warning, according to The World Hypertension League and leading international health organisations.

27 Sep 2019

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.

27 Sep 2019

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.

27 Sep 2019

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

27 Sep 2019

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy did not increase myocardial infarction or stent thrombosis in high bleeding risk patients treated with a contemporary drug-eluting stent.

27 Sep 2019

Biological clock responds positively to stress

In a recent study, researchers found that the integrated stress response (ISR) is essential to stimulate the circadian clock.

27 Sep 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

High-risk heart patients may not require long-term aspirin use after stent placement

High-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement, Mount Sinai researchers report in a groundbreaking study

26 Sep 2019

Mount Sinai researchers identify elemental signatures in baby teeth unique to ADHD and autism

Mount Sinai researchers have identified elemental signatures in baby teeth that are unique to attention-deficit/hyperactivity disorder, autism spectrum disorder, and cases when both neurodevelopment conditions are present, which suggests that the metabolic regulation of nutrients and toxins play a role in these diseases, according to a study published in Translational Psychiatry in September.

26 Sep 2019

Researcher aims to make CRISPR-Cas9 system safer and more precise

The mere mention of gene editing and DNA altering might conjure up images of designer babies, but that is not what researcher Jin Liu has in mind.

26 Sep 2019

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

26 Sep 2019

New NIH program aims to improve lives for people with inherited blood and immune diseases

People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.

26 Sep 2019

Heart Disease News and Research

Latest Heart Disease News and Research

Experts: Tobacco-style health warning labels are mandatory on salt shakers

Polymer drug-eluting and polymer-free drug-coated stents safe and effective for patients with high bleeding risk

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Biological clock responds positively to stress

FDA warns about Ranitidine containing known carcinogen NDMA

High-risk heart patients may not require long-term aspirin use after stent placement

Mount Sinai researchers identify elemental signatures in baby teeth unique to ADHD and autism

Researcher aims to make CRISPR-Cas9 system safer and more precise

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

New NIH program aims to improve lives for people with inherited blood and immune diseases

Living in greener neighborhoods linked to lower risk of metabolic syndrome

Oral health plays increasing role in overall health of the elderly

Volatile substances inhaled during chroming may ‘dissolve the brain’

Minimum unit pricing of alcohol leads to consumption decline in Scotland

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

AI technique helps detect people at risk of heart failure

Research findings open the way for more heart donations

Researchers identify novel genetic variants linked to plasma lipid levels and cardiovascular risk

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in